NEW YORK, Oct. 30 /PRNewswire/ —
See video from Novartis at:
Novartis announced that the US Food and Drug Administration
(FDA) has approved Afinitor®; (everolimus) tablets for patients
with subependymal giant cell astrocytoma (SEGA), a benign brain
tumor associated with tuberous sclerosis (TS), who require
therapeutic intervention but are not candidates for curative
surgical resection. Available material includes soundbites.
thenewsmarket.com delivers free broadcast- and streaming-quality
video and multimedia content directly to media around the world,
24/7. More than 25,000 media outlets in 190+ countries use
thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24,
N24, nytimes.com, RAI, TVE and ZDF.
Registered journalists can access video, audio, text, graphics
and photos at http://www.thenewsmarket.com.
If you are not already registered, please take a moment to sign
up – registration is quick and free: http://www.thenewsmarket.com/registration